In addition to the cases mentioned, CCL2 is produced by cancer cells, and TAMs and CAFs (cancer-associated fibroblast) can react with the CCR2 receptor expressed on the surface of cancer cells and cause its activation, which subsequently increases the proliferation, migration, and resistance of cancerous cells to apoptosis. This evidence concerns the gene CCL2 and cancer.